Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles: 2020-2023

Historic Amortizatization of Intangibles for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Dec 2023 value amounting to $29,000.

  • Mirum Pharmaceuticals' Amortizatization of Intangibles fell 97.15% to $29,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.7 million, marking a year-over-year increase of 1.29%. This contributed to the annual value of $1.7 million for FY2023, which is 1.29% up from last year.
  • Mirum Pharmaceuticals' Amortizatization of Intangibles amounted to $29,000 in Q4 2023, which was down 87.61% from $234,000 recorded in Q3 2023.
  • In the past 5 years, Mirum Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $1.0 million in Q4 2022 and a low of -$148,000 during Q4 2021.
  • Over the past 3 years, Mirum Pharmaceuticals' median Amortizatization of Intangibles value was $98,500 (recorded in 2021), while the average stood at $297,083.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Amortizatization of Intangibles slumped by 285.00% in 2021, and later spiked by 31,550.00% in 2023.
  • Mirum Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at $80,000 in 2020, then crashed by 285.00% to -$148,000 in 2021, then skyrocketed by 787.16% to $1.0 million in 2022, then crashed by 97.15% to $29,000 in 2023.
  • Its Amortizatization of Intangibles stands at $29,000 for Q4 2023, versus $234,000 for Q3 2023 and $633,000 for Q2 2023.